IFPMA Covid-19 Günlük Bülteni – 13 Mayıs

13.05.2020

Top news:

  • Negotiators of the EU resolution have agreed on a draft text on IP rights over COVID-19 tools which will be tabled at next week’s WHA.
  • WHO published the 2020 World Health Statistics today – despite progress, particularly in lower-income countries, the report reflects that the rate of progress is too slow to meet the Sustainable Development Goals and will be further thrown off track by COVID-19.
  • WHO chief scientist Soumya Swaminathan said it will be four or five years before Covid-19 is under control.
  • Sanofi to potentially give US preference on COVID-19 vaccine citing it being first in line to fund its vaccine research.
  • Gilead signed non-exclusive voluntary licensing agreements with 5 generic pharmaceutical manufacturers to produce remdesivir for 127 countries.
  • EU Commission is weighing using a $2.6 billion emergency fund to boost pharma companies’ manufacturing capacity, fearing shortages of a COVID-19 vaccine once it’s developed

ACCESS & AVAILABILITY

SUPPLY & MANUFACTURING

GLOBAL RESPONSE

  • Gates Foundation: A down payment on a COVID-free future.  No one knows yet who will discover the first effective coronavirus vaccine, or where it will be made. What we do know is that governments, corporations, multilateral institutions, and philanthropic organizations need to work with each other to meld their unique resources into a collective effort.

GLOBAL ECONOMIC IMPACT

  • Financial Times: European investment plunge raises fears for future growth. Across the region, capital expenditure has contracted sharply, according to data for countries that have published detailed gross domestic product data, while borrowing to invest has dropped across the eurozone, reflecting businesses’ rising cash needs and plummeting output.
  • Financial Times: Emerging economies hold back on asking creditors for debt relief. Renegotiating borrowing from private investors could damage future access to finance. The G20 group of leading nations has agreed to suspend repayments on bilateral debt from 73 poor countries. It also asked private creditors to do the same.

GLOBAL HEALTH IMPACT

TREATMENT & VACCINE DEVELOPMENT

IFPMA members

  • The Wall Street Journal: Gilead’s Remdesivir Tested With Other Drugs to Fight COVID-19. The promise and limitations of remdesivir, the first drug to prove capable of helping fight COVID-19, have kicked off efforts to see if it can work better in combination with other treatments and to create new, easier methods of administering it.

Others – Vaccines

Others – Treatments

Ethics

PREPAREDNESS

GEOPOLITICS

WHO – COVID-19 UPDATE, 13 May

Statement by Dr Tedros during today’s media briefing here.

  • Today, the 2020 World Health Statistics were published by WHO.
    • The biggest gains were reported in low-income countries, which saw life expectancy rise by more than a fifth since the turn of the Millennium.
    • Better maternal and child healthcare has led to a halving of child mortality since the year 2000.
    • Furthermore, lower-income countries dramatically scaled up access to services to prevent and treat HIV, malaria and tuberculosis, as well as a number of neglected tropical diseases such as guinea worm.
    • However, the report reflects that the rate of progress is too slow to meet the Sustainable Development Goals and will be further thrown off track by COVID-19.
    • The new statistics shine a light on one of the key drivers of this pandemic: inequality.
  • During the World Health Assembly next week we will discuss with health leaders from across the world not only how to defeat COVID-19 but also how we can build back stronger health systems everywhere.
  • We urge political leaders to ensure that COVID-19 preparedness and responses in closed settings are identified and implemented in line with fundamental human rights and are guided by WHO guidance and recommendations to protect human health.
  • The WHO Academy app provides health workers with mobile access to a wealth of COVID-19 resources, developed by WHO, that include up-to-the-minute guidance, tools, training, and virtual workshops that will help them care for COVID-19 patients and protect themselves.
  • Furthermore, in response to COVID-19, WHO has utilized our OpenWHO platform and translated guidance into training, including 68 online courses to improve the response to health emergencies.

WHO: UNODC, WHO, UNAIDS and OHCHR joint statement on COVID-19 in prisons and other closed settings. They want to urgently draw the attention of political leaders to the heightened vulnerability of prisoners and other people deprived of liberty to the COVID-19 pandemic, and urge them to take all appropriate public health measures in respect of this vulnerable population that is part of our communities.

WHO: Launch of the WHO Academy and the WHO Info mobile applications. The WHO Academy app is designed to support health workers during COVID-19. The app provides health workers with mobile access to a wealth of COVID-19 knowledge resources, develop. The WHO Info app is designed to inform the general public and will give real-time mobile access to the latest news and developments.

PAHO: PAHO Director asks countries to address health, social and economic emergencies together, as COVID-19 expands in the Americas. Carissa F. Etienne, Director of PAHO, called on countries to address health, social and economic emergencies, saying she is “deeply concerned” by the rapid expansion of the COVID-19 pandemic in the Americas. She urged that countries must support their economies while building strong social protection networks and embracing evidence-based public health measures that are essential to saving lives.